Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 106 CD 34 + Cells Per Kg in ≤ 3 Apheresis)
H.C. Fung, J. Tornatta, B. McLeod, S. Nathan, J. Maciejewski, E. Rich, R. Karmali, A. Jimenez, K.W. Christopherson II, S.A. GregoryVolume:
18
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2011.12.175
File:
PDF, 57 KB
english, 2012